Effectiveness of low-carbohydrate diets on type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials in Eastern vs. Western populations
{"title":"Effectiveness of low-carbohydrate diets on type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials in Eastern vs. Western populations","authors":"Pichanun Mongkolsucharitkul , Apinya Surawit , Apiradee Pimsen , Siriluk Winitchayothin , Sureeporn Pumeiam , Bonggochpass Pinsawas , Suphawan Ophakas , Sophida Suta , Phongthana Pasookhush , Korapat Mayurasakorn","doi":"10.1016/j.diabres.2025.112464","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Low-carbohydrate diets (LCDs) have emerged as a potential dietary intervention for managing glycemic control, but their effectiveness across different cultural contexts remains unclear. To evaluate the efficacy of LCDs in managing type 2 diabetes, with attention to cultural context, and to clarify how variability in carbohydrate definitions affects interpretation.</div></div><div><h3>Methods</h3><div>We searched PubMed, Embase, and Scopus from inception to 1 August 2024 for randomized controlled trials (RCTs) ≥ 12 weeks in adults with type 2 diabetes. We conducted exploratory analyses by Eastern versus Western setting and dose–response <em>meta</em>-regression using actual carbohydrate intake at the follow-up.</div></div><div><h3>Results</h3><div>Twenty-seven RCTs (n = 2,870; 7 Eastern, 20 Western) were included. Across analyzed time points, no arm sustained carbohydrate intake < 10 % of total energy; therefore, findings generalize to low-to-moderate carbohydrate rather than very-low-carbohydrate. LCDs improved glycemia short-term: HbA1c − 0.29 %, with the largest effect at 3 months. Fasting blood glucose decreased overall (−7.12 mg/dL). Weight loss was greatest at 3 months and attenuated thereafter. At 3 months, lower actual carbohydrate intake was related to larger HbA1c and weight reductions.</div></div><div><h3>Conclusions</h3><div>LCDs offer modest, short-term metabolic benefits for type 2 diabetes management, but benefits diminish over time. Cultural context may shape responses, underscoring individualized, culturally tailored care.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"229 ","pages":"Article 112464"},"PeriodicalIF":7.4000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725004784","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
Low-carbohydrate diets (LCDs) have emerged as a potential dietary intervention for managing glycemic control, but their effectiveness across different cultural contexts remains unclear. To evaluate the efficacy of LCDs in managing type 2 diabetes, with attention to cultural context, and to clarify how variability in carbohydrate definitions affects interpretation.
Methods
We searched PubMed, Embase, and Scopus from inception to 1 August 2024 for randomized controlled trials (RCTs) ≥ 12 weeks in adults with type 2 diabetes. We conducted exploratory analyses by Eastern versus Western setting and dose–response meta-regression using actual carbohydrate intake at the follow-up.
Results
Twenty-seven RCTs (n = 2,870; 7 Eastern, 20 Western) were included. Across analyzed time points, no arm sustained carbohydrate intake < 10 % of total energy; therefore, findings generalize to low-to-moderate carbohydrate rather than very-low-carbohydrate. LCDs improved glycemia short-term: HbA1c − 0.29 %, with the largest effect at 3 months. Fasting blood glucose decreased overall (−7.12 mg/dL). Weight loss was greatest at 3 months and attenuated thereafter. At 3 months, lower actual carbohydrate intake was related to larger HbA1c and weight reductions.
Conclusions
LCDs offer modest, short-term metabolic benefits for type 2 diabetes management, but benefits diminish over time. Cultural context may shape responses, underscoring individualized, culturally tailored care.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.